APOPTOSIS INDUCING PRODUCT AND METHOD FOR MANUFACTURING SAME, APOPTOSIS INDUCER AND METHOD OF APOPTOSIS INDUCING, INDUCER FOR DIFFERENTIATION OF CANCEOUS CELLS, FOOD PRODUCT, PHARMACEUTICAL COMPOSITIONS AND HYGIENIC MEANS

摘要

1. An apoptosis inducing product obtained by heating at a temperature from room to 350 degree C for several seconds to several days under acidic to neutral conditions at least one substance selected from the following (a), (b) and (c): (a) uronic acid or uronic acid derivative; (b) a saccharide compound containing uronic acid or a saccharide compound containing uronic acid derivative; and (c) a substance containing a saccharide compound containing uronic acid or a substance containing a saccharide compound containing uronic acid derivative. 2. A product according to claim 1 wherein uronic acid is galacturonic acid, glucuronic acid, guluronic acid, mannuronic acid and/or iduronic acid. 3. A product according to claim 1 wherein the derivative is uronic acid lactone, uronic acid ester, uronic acid amide or salt thereof. 4. A heat-treated product according to claim 1 wherein the saccharide compound is a saccharide compound which is selected from pectin, pectic acid, alginic acid, hyaluronic acid, heparin, fucoidan, chondroitin sulfate, chondroitin, dermatan sulfate and/or decomposed product thereof. 5. A product according to any of claims 1-4 wherein the heat-treated product is obtained by heating at 60-350 degree C for several seconds to several days. 6. A heat-treated product according to any of claims 1-5 wherein the heat-treated product is a product obtained by means of a molecular weight fractionation. 7. A food product which is characterized in containing the heat-treated product mentioned in any of claims 1-6. 8. A food product having an anticancer action which is characterized in containing the heat-treated product mentioned in any of claims 1-6. 9. Antibacterial agent which is characterized in containing any of the heat-treated product mentioned in any of claims 1-6. 10. Antiseptic agent which is characterized in containing the antibacterial agent of claim 9. 11. Dentifrice which is characterized in containing the antibacterial agent of claim 9. 12. An apoptosis-inducer which is characterized in containing the heat-treated product of claim 1-6. 13. An anticancer agent which is characterized in containing the heat-treated product of claim 1-6. 14. An inducer for differentiation of cancerous cells which is characterized in containing the heat-treated product of claim 1-6. 15. Antiulcer agent which is characterized in containing the heat-treated product of claim 1-6. 16. A method of inducing an apoptosis which is characterized in using the heat-treated product of claim 1-6 as an effective component. 17. A method for the manufacture of an apoptosis inducing product obtained by heating at a temperature from room to 350 degree C for several seconds to several days under acidic to neutral conditions at least one substance selected from the following (a), (b) and (c): (a) uronic acid or uronic acid derivative; (b) a saccharide compound containing uronic acid or a saccharide compound containing uronic acid derivative; and (c) a substance containing a saccharide compound containing uronic acid or a substance containing a saccharide compound containing uronic acid derivative. 18. A method according to claim 17 wherein uronic acid is galacturonic acid, glucuronic acid, guluronic acid, mannuronic acid and/or iduronic acid. 19. A method according to claim 17 wherein the derivative is uronic acid lactone, uronic acid ester, uronic acid amide or salt thereof. 20. A method according to claim 17 wherein the saccharide compound is a saccharide compound which is selected from pectin, pectic acid, alginic acid, hyaluronic acid, heparin, fucoidan, chondroitin sulfate, chondroitin, dermatan sulfate and/or decomposed product thereof. 21. A method according to any of claims 17-20 wherein the heating is a treatment which is conducted at 60-350 degree C for several seconds to several days. 22. A method according to any of claims 17-21 wherein the heating is a treatment which is conducted under acidic to neutral conditions. 23. A method according to any of claims 17-22 wherein a step of conducting a molecular weight fractionation of the heat-treated product is included.